The law firm of Wohl & Fruchter LLP is investigating the acquisition of Chindex International Inc. (Chindex) (Nasdaq: CHDX) by a group consisting of Shanghai Fosun Pharmaceutical Group Co. (Fosun), private-equity firm TPG Capital (TPG), and Chindex’s co-founder, President and CEO, Roberta Lipson (Lipson).

On February 17, 2014, Chindex announced that it had agreed to be acquired by TPG, Fosun and Lipson for a price of $19.50 per share in cash, a mere premium of 13.7% over the closing price of Chindex on February 14, 2014.

According to Chindex’s proxy statement filed on April 22, 2013, in advance of the Company’s 2013 annual meeting of shareholders, an affiliate of Fosun owns 19.9% of the common stock of Chindex.

On November 11, 2013, in connection with Chindex’s announcement of its financial results for the third quarter of 2013, Lipson stated: “The Chinese government has recently made unprecedented pronouncements on the key role of private healthcare in the continued healthcare reform process, reiterating the expectation that 20% of care will come from the private sector by 2015, and that by 2020 the healthcare market will be an RMB 8 trillion (USD$1.3 trillion) industry. Chindex is best positioned as the earliest and largest private premium healthcare provider in China to capture this tremendous opportunity.”

Wohl & Fruchter’s investigation concerns the fairness of the consideration being provided to Chindex shareholders, and whether approval of the merger was improperly motivated by conflicts of interest.

Persons with relevant information, and CHDX shareholders with questions about this investigation, are invited to contact our Firm by calling 866.833.6245, or contacting the attorney below.

Additional information is available at  http://www.wohlfruchter.com/cases/chdx.

About Wohl & Fruchter

Wohl & Fruchter LLP represents plaintiffs in litigation arising from fraud and other fiduciary breaches by corporate managers, as well as other complex litigation matters. Please visit our website, www.wohlfruchter.com, to learn more about our Firm, or contact one of our partners.

Contact:

J. Elazar Fruchter ( jfruchter@wohlfruchter.com)845.425.4658Wohl & Fruchter LLP570 Lexington AvenueNew York, NY 10022 www.wohlfruchter.com

This release may be deemed to constitute attorney advertising.

Copyright Business Wire 2010